115 related articles for article (PubMed ID: 36273731)
21. Adjuvant chemotherapy and overall survival in adult medulloblastoma.
Kann BH; Lester-Coll NH; Park HS; Yeboa DN; Kelly JR; Baehring JM; Becker KP; Yu JB; Bindra RS; Roberts KB
Neuro Oncol; 2017 Feb; 19(2):259-269. PubMed ID: 27540083
[TBL] [Abstract][Full Text] [Related]
22. Utilization and impact of adjuvant therapy in anaplastic oligodendroglioma: an analysis on 1692 patients.
Shin JY; Diaz AZ
J Neurooncol; 2016 Sep; 129(3):567-575. PubMed ID: 27401158
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant Chemoradiotherapy in Resected Pancreatic Ductal Adenocarcinoma: Where Does the Benefit Lie? A Nomogram for Risk Stratification and Patient Selection.
Naffouje SA; Sabesan A; Kim DW; Carballido E; Frakes J; Hodul P; Denbo JW; Malafa M; Fleming J; Hoffe S
J Gastrointest Surg; 2022 Feb; 26(2):376-386. PubMed ID: 34506031
[TBL] [Abstract][Full Text] [Related]
24. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer.
Yan F; Li H; Kaczmar JM; Sharma AK; Day TA; Neskey DM; Pipkorn P; Zenga J; Graboyes EM
JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1109-1119. PubMed ID: 32790830
[TBL] [Abstract][Full Text] [Related]
25. The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population.
Rusthoven CG; Carlson JA; Waxweiler TV; Dally MJ; Barón AE; Yeh N; Gaspar LE; Liu AK; Ney DE; Damek DM; Lillehei KO; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):894-902. PubMed ID: 25585784
[TBL] [Abstract][Full Text] [Related]
26. The Effectiveness of Chemoradiotherapy in Elderly Patients with Pancreatic Cancer: A Population-Based Study Based on the SEER Database.
Nie D; Liu S; Cai S; Xing X; Xu F
Adv Ther; 2022 Nov; 39(11):5043-5057. PubMed ID: 36044179
[TBL] [Abstract][Full Text] [Related]
27. Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: A surveillance, epidemiology, and end results-based study.
Hochfelder CG; McGinn AP; Mehta V; Castellucci E; Kabarriti R; Ow TJ
Laryngoscope; 2020 Nov; 130(11):2611-2621. PubMed ID: 31821572
[TBL] [Abstract][Full Text] [Related]
28. Who benefits from chemoradiation in stage III-IVA endometrial cancer? An analysis of the National Cancer Data Base.
Lester-Coll NH; Park HS; Rutter CE; Corso CD; Young MR; Ratner ES; Litkouhi B; Decker RH; Yu JB; Damast S
Gynecol Oncol; 2016 Jul; 142(1):54-61. PubMed ID: 27151429
[TBL] [Abstract][Full Text] [Related]
29. Survival benefit of adjuvant chemoradiotherapy for positive or close resection margin after curative resection of pancreatic adenocarcinoma.
Kim BH; Kim K; Jang JY; Kwon W; Kim H; Lee KH; Oh DY; Kim H; Lee KB; Chie EK
Eur J Surg Oncol; 2020 Nov; 46(11):2122-2130. PubMed ID: 32782200
[TBL] [Abstract][Full Text] [Related]
30. Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base.
Jhaveri J; Liu Y; Chowdhary M; Buchwald ZS; Gillespie TW; Olson JJ; Voloschin AD; Eaton BR; Shu HG; Crocker IR; Curran WJ; Patel KR
Cancer; 2018 Mar; 124(6):1169-1178. PubMed ID: 29205287
[TBL] [Abstract][Full Text] [Related]
31. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy alone for patients with locally advanced rectal cancer: a propensity-score-matched analysis combined with SEER validation.
Wu J; Huang M; Wu Y; Hong Y; Cai L; He R; Luo Y; Wang P; Huang M; Lin J
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8897-8912. PubMed ID: 37154929
[TBL] [Abstract][Full Text] [Related]
33. Improving survival of stage II-III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy.
Li Y; Zhu Z; Ma F; Xue L; Tian Y
Cancer Med; 2020 Sep; 9(18):6617-6628. PubMed ID: 32744431
[TBL] [Abstract][Full Text] [Related]
34. Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis.
Girardi DM; de Lima MA; Pereira GCB; Negrão MV; López RVM; Capareli FC; Sabbaga J; Hoff PMG
BMC Cancer; 2018 Apr; 18(1):378. PubMed ID: 29614980
[TBL] [Abstract][Full Text] [Related]
35. Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer.
Morganti AG; Falconi M; van Stiphout RG; Mattiucci GC; Alfieri S; Calvo FA; Dubois JB; Fastner G; Herman JM; Maidment BW; Miller RC; Regine WF; Reni M; Sharma NK; Ippolito E; Valentini V
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):911-7. PubMed ID: 25220717
[TBL] [Abstract][Full Text] [Related]
36. Choosing the right adjuvant therapy for stage III-IVA endometrial cancer: A comparative analysis of chemoradiotherapy and chemotherapy.
Kim HJ; Lee J; Lee KB; Sung K; Kim YB; Kim YS
Gynecol Oncol; 2024 Mar; 182():39-44. PubMed ID: 38246045
[TBL] [Abstract][Full Text] [Related]
37. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma.
Bédard EL; Inculet RI; Malthaner RA; Brecevic E; Vincent M; Dar R
Cancer; 2001 Jun; 91(12):2423-30. PubMed ID: 11413534
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Factors and Effect of Adjuvant Chemoradiation Following Chemotherapy in Resected Pancreatic Cancer Patients With Lymph Node Metastasis or R1 Resection.
Xing J; Yang B; Hou X; Jia N; Gong X; Li X; Zhou N; Cheng Y; Bai C
Front Oncol; 2021; 11():660215. PubMed ID: 34631515
[TBL] [Abstract][Full Text] [Related]
39. Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective cohort study.
Pu N; Wu W; Liu S; Xie Y; Yin H; Chen Q; He T; Xu Z; Wang W; Yu J; Liu L; Lou W
Int J Surg; 2023 Oct; 109(10):3137-3146. PubMed ID: 37418574
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant therapy for margin positive pancreatic cancer: A propensity score matched analysis.
Takahashi C; Shridhar R; Huston J; Meredith K
Pancreatology; 2022 Apr; 22(3):396-400. PubMed ID: 35304103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]